- Filed
- Jun 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jun 20, 2025 | 25M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 25M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 25M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$675.95K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$461.45K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $63.11K |
| Cash And Equivalents | Q1 2025 · Jan 1, 2025 | $62.31K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $62.31K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$5.03M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$4.28M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$2.39M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$1.91M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.95M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.47M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $9.08M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $8.69M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.24M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.45M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.05M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.41M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.03 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $421.8K |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $368.8K |
| Net Income | Q1 2025 · Mar 31, 2025 | −$721.71K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$603.6K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$682.49K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$621.25K |
| Revenue | Q1 2025 · Mar 31, 2025 | $398.83K |
| Revenue | Q1 2025 · Mar 31, 2024 | $851.56K |
| Capex | Q1 2025 · Mar 31, 2024 | $41.05K |